Leveraging a team of highly experienced individuals to facilitate unmet clinical needs.

ReFormation Pharmaceuticals Corp is a Pharmaceutical company headquartered in Toronto, Canada with Research and Development operations at the University of Oxford. ReFormation focuses on an innovative approach to repair vital organs by targeting an endogenous trigger of repair (HMGB1).

ReFormation is based on disruptive technology which will deliver a first in class therapeutic. We have identified a molecule that primes the body’s own stem cells from a diverse range of tissues to accelerate repair and regeneration following acute or chronic injury.

ReFORMATION TARGETS

ReFormation is based on disruptive technology which will deliver a first in class therapeutic. We have identified a molecule that primes the body’s own stem cells from a diverse range of tissues to accelerate repair and regeneration following acute or chronic injury.